A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis

NCT01269229 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: folfox
RADIATION: short course Radiotherapy

Sponsor

Yonsei University